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Synthesis of pyrazole containing α-amino acids via
a highly regioselective condensation/aza-Michael
reaction of β-aryl α,β-unsaturated ketones†
Lynne Gilﬁllan,a Raik Artschwager,a Alexander H. Harkiss,a Rob M. J. Liskampa,b and
Andrew Sutherland*a
A synthetic approach for the preparation of a new class of highly conjugated unnatural α-amino acids
bearing a 5-arylpyrazole side-chain has been developed. Horner–Wadsworth–Emmons reaction of an
aspartic acid derived β-keto phosphonate ester with a range of aromatic aldehydes gave β-aryl α,β-un-
saturated ketones. Treatment of these with phenyl hydrazine followed by oxidation allowed the regio-
selective synthesis of pyrazole derived α-amino acids. As well as evaluating the ﬂuorescent properties of
the α-amino acids, their synthetic utility was also explored with the preparation of a sulfonyl ﬂuoride
derivative, a potential probe for serine proteases.
Introduction
With continued advances in chemical biology and biomedical
and life sciences, non-proteinogenic α-amino acids are being
increasingly used as probes to study the mechanism of biologi-
cal processes, investigate the bioactive conformations of pro-
teins and facilitate the discovery of new pharmacologically
active compounds.1,2 Furthermore, in the field of organic syn-
thesis, many unnatural α-amino acids have been used as chiral
building blocks, ligands and catalysts.3 Due to this increasing
range of applications, novel classes of non-proteinogenic
α-amino acids and methods for their synthesis are still very
much in demand.2,3
In recent years, there has been much interest in developing
the synthesis and applications of unnatural α-amino acids
with heteroaryl containing side-chains.2,4 For example, follow-
ing the isolation and discovery of a naturally occurring pyra-
zole containing α-amino acid, (S)-β-pyrazolylalanine (1) (Fig. 1)
from Citrullus vulgaris,5 various biological applications of
novel pyrazole containing α-amino acids have been reported.
Pyrazole analogues of ibotenic acid were shown to be selective
antagonists of the metabotropic glutamate receptor
2 (mGluR2),6 while a number of 3-carboxypyrazole α-amino
acids (e.g. 2) are antagonists of the N-methyl-D-aspartic acid
(NMDA) receptor.7 The antitumor activity of ferrocenyl derived
α-amino acids linked via a pyrazole moiety has also been
demonstrated.8 Other applications include using the rigidity of
the pyrazole moiety to generate conformationally restricted
peptidomimetics such as α-amino acid 3, which mimics the
cis-amide bond.9 Despite exhibiting a range of interesting pro-
perties and applications, flexible and general synthetic routes
for the preparation of optically active pyrazole containing
α-amino acids are still relatively limited.5b,7,9–11 Noteworthy
approaches include the cyclocondensation of α-hydrazino-
amino acids with 3-trimethylsilanylpropynones or enamino
ketones.9 More recently, Conti and co-workers prepared 3-carb-
oxypyrazole derivatives via a 1,3-dipolar cycloaddition of allyl-
glycine with hydrazine derived nitrilimines,7 while Wei and
Lubell used the nucleophilic ring-opening of serine derived
cyclic sulfamidates for the preparation of β-diketone α-amino
acids which were then converted to the corresponding pyrazole
by condensation with hydrazine.10a
Fig. 1 Biologically active pyrazole containing α-amino acids.
†Electronic supplementary information (ESI) available: Experimental procedures
and data for all known compounds and NMR spectra for all new compounds.
See DOI: 10.1039/c5ob00364d
aWestCHEM, School of Chemistry, The Joseph Black Building, University of Glasgow,
Glasgow, G12 8QQ, UK. E-mail: Andrew.Sutherland@glasgow.ac.uk;
Tel: +44 (0)141 330 5936
bDepartment of Medicinal Chemistry and Chemical Biology, Faculty of Science,
Utrecht University, P. O. Box 80082, 3508 TB Utrecht, The Netherlands
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Recently, we reported an eﬃcient approach for the prepa-
ration of a rare class of α-amino acid with enone side chains.12
In exploring the reactivity and application of these amino
acids, we discovered that these could undergo selective 6-endo-
trig cyclisations for the synthesis of 4-oxopipecolic acids,13 and
had potential as biological probes with the preparation of a
highly fluorescent 4-dimethylamino-1-naphthyl enone ana-
logue.12 Despite these advances, we found that on long-term
storage, the enones were prone to decomposition. In an eﬀort
to further explore the reactivity of these compounds and
produce more robust biologically functional probes, we pro-
posed to investigate heterocyclisation reactions of the enone
derived α-amino acids. We now report the development of a
highly regioselective condensation/aza-Michael reaction as the
key step for the preparation of a new class of α-amino
acids bearing 5-arylpyrazole side-chains (Scheme 1). As well as
exploring selective deprotection strategies to the parent
α-amino acids and measuring their fluorescent properties, the
application of one of these compounds for the preparation of
a sulfonyl fluoride, well-established serine protease inhibitors
is also described.
Results and discussion
The project began with the preparation of a series of enone
derived α-amino acids (Scheme 2).12,13 Reaction of L-aspartic
acid (4) with thionyl chloride in methanol followed by N-trityl
protection under basic conditions gave N-trityl L-aspartate
dimethyl ester 5 in quantitative yield.14 Using the N-trityl
group to block the α-methyl ester allowed the highly regioselec-
tive reaction of 5 with the lithium anion of dimethyl methyl-
phosphonate. This gave β-ketophosphonate ester 6 as the sole
product in 92% yield. To generate stable, highly conjugated
heterocycle derived α-amino acids with the potential to act as
fluorescent probes, enones with β-aryl side chains were pre-
pared. Under mild conditions, Horner–Wadsworth–Emmons
reaction of 6 with various aryl aldehydes gave the corres-
ponding β-aryl E-enones 7–11 in high yields (72–95%). As
expected, the reactions of the electron deficient aldehydes
were complete after 24 h, while the electron rich and more
conjugated analogues required extended reaction times
(36–72 h). While other methods have recently been reported
for the preparation of these types of enone derived α-amino
acids,15 the approach described in Scheme 2 is particularly
robust, allowing the multi-gram synthesis of these compounds
in excellent overall yields from L-aspartic acid.
Methods for formation of the pyrazoles via 2-pyrazolines by
reaction of enones 7–11with phenyl hydrazine were next investi-
gated. Under neutral or acidic conditions, 2-pyrazolines can
be prepared by the reaction of enones and hydrazines through
a two-stage process involving imine condensation to form a
hydrazone, followed by an aza-Michael reaction to complete
the cyclisation.16 Initially, reaction of 7 with phenyl hydrazine
was attempted under neutral conditions. However, analysis by
1H NMR spectroscopy showed that the reaction had not gone
to completion forming only the hydrazone intermediate. As
more forcing, acidic conditions were necessary, the acid-labile
N-trityl protected α-amino acids 7–11 were converted to the
N-Cbz derivatives (Scheme 3). Amino acids 7–11 were easily
deprotected using TFA under mild conditions. Without purifi-
cation, the resulting amines were treated with benzyl chloro-
formate in the presence of Hünig’s base, which gave the Cbz-
derivatives 12–16 in high yields over the two-steps (77–87%).
Reaction of N-Cbz protected enone 12 with phenyl hydrazine
in the presence of HCl was then investigated. Under reflux con-
ditions, this produced the corresponding 2-pyrazoline cleanly,
as a single regioisomer. While not important for the synthesis
of pyrazoles, it was noted using NMR spectroscopy that the
aza-Michael step proceeded without any asymmetric bias from
the chiral α-position, forming a 1 : 1 mixture of diastereomers.
Without purification, the 2-pyrazoline was oxidised using DDQ
under mild conditions and this gave pyrazole 17 in 76% yield
over the two-steps.17 With an optimised approach in hand, the
scope of this process was then explored using the other enones
with electron-rich, electron-deficient and highly conjugated
side-chains. With all the examples, the corresponding
pyrazoles were formed as a single regioisomer in high yields
(73–84%).
Scheme 2 Synthesis of β-aryl E-enones.Scheme 1 Proposed approach to novel 5-arylpyrazole α-amino acid
derivatives.
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To access the parent α-amino acids, various strategies were
explored. We wanted to demonstrate that the α-carboxylic acid
position could be selectively deprotected under mild con-
ditions to give N-Cbz protected α-amino acids that could have
direct application in peptide synthesis. Using compounds 17,
19 and 20, hydrolysis of the ester moiety with cesium carbon-
ate at room temperature gave the N-Cbz protected α-amino
acids cleanly (Scheme 4). Without purification, removal of the
amino protecting group under acidic conditions then gave
α-amino acids 22–24 in 79–88% yields over the two steps.
Using the nitro-substituted α-amino acids, a one-step pro-
cedure was also developed. Acid mediated deprotection of
compounds 18 and 21 using 6 M HCl resulted in the removal
of both protecting groups, allowing the isolation of α-amino
acids 25 and 26 in essentially quantitative yields. Overall, this
approach for the preparation of α-amino acids bearing 5-aryl-
pyrazole side-chains was general and eﬃcient, allowing the
synthesis of the target α-amino acids in 36–53% overall yield
from L-aspartic acid.
The specific use of aryl substituents for the pyrazoles was to
generate α-amino acids with highly conjugated side-chains
that would possess fluorescent properties.18 Therefore, follow-
ing the synthesis of compounds 22–26, the absorption and
fluorescence spectra were recorded (Table 1). The absorption
and emission maxima showed some correlation with the
electronic nature of the aryl substituents. For example, the
electron deficient groups generally absorbed and emitted at
longer wavelengths. While compounds 22–26 all showed some
degree of fluorescence, the naphthyl and 4-nitrophenyl ana-
logues 24 and 25, in particular showed strong fluorescence
with maxima at 356 and 415 nm, respectively (Fig. 2).
The emission maxima for the naturally occurring α-amino
acid, tryptophan occurs at similar wavelength (λEm = 352 nm)
to naphthyl analogue 24.19 This would obviously limit appli-
cations of 24 when incorporated into proteins and peptides
Scheme 3 Synthesis of pyrazole derived α-amino acids 17–21.
Fig. 2 Emission spectra for α-amino acids 24 and 25.
Scheme 4 Deprotection strategies for preparation of α-amino acids
22–26.
Table 1 Absorbance and emission data for compounds 22–26a
Compound λAbs (nm) λEm (nm) ε (cm
−1 M−1)
22 250 367 13 320
23 254 348 6170
24 249 356 23 650
25 303 415 10 060
26 270 434 26 940
a The spectra were recorded in methanol at a concentration of 1 × 10–5 M.
Paper Organic & Biomolecular Chemistry
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containing tryptophan. So despite showing weaker
fluorescence, it was decided to investigate applications of
4-nitrophenyl analogue 25, which has an emission maximum
at higher wavelength compared to proteinogenic α-amino
acids.20
Sulfonyl fluorides derived from α-amino acids and peptides
have been synthesised and shown to act as electrophilic traps
for the potent inhibition of protease enzymes.21,22 In particu-
lar, a N-Cbz protected tetrapeptide incorporating a sulfonyl
fluoride unit has demonstrated broad-spectrum antimalarial
activity.23 In this project, we wished to investigate whether a
sulfonyl fluoride unit could be incorporated into 5-(4′-nitro-
phenyl)pyrazole α-amino acid 18. The product of this process
would generate a multi-functional compound that would have
potential as both a protease inhibitor and could undergo
further transformations such as peptide synthesis for develop-
ment as a biological probe. The ester moiety of 18 was initially
reduced under mild conditions using sodium borohydride and
lithium chloride (Scheme 5). This gave alcohol 27 in 95%
yield. The hydroxyl group was activated as the mesylate under
standard conditions, and this was then displaced by in situ
generated cesium thioacetate forming 29 in high yield.
Oxidation of thioacetate 29 with aqueous hydrogen peroxide
in the presence of sodium acetate gave the corresponding
sodium sulfonate salt in quantitative yield. Sodium sulfonates
can be converted to sulfonyl fluorides by treatment with oxalyl
chloride and then reaction of the resulting sulfonyl chloride
with potassium fluoride, or directly using DAST.21,22a For the
preparation of sulfonyl fluoride 31, it was found that direct
reaction of the sodium sulfonate salt with triethylamine
trihydrofluoride and XtalFluor-M® 30 gave the target com-
pound very cleanly, in 64% yield. The synthesis of sulfonyl
fluoride 31 in 48% overall yield from 18 demonstrates the
synthetic utility of pyrazole derived α-amino acids and their
use for the synthesis of potential functionalised biological
probes.
Conclusions
In summary, a series of novel pyrazole derived α-amino acids
have been prepared from L-aspartic acid using highly regio-
selective transformations such as a Horner–Wadsworth–
Emmons reaction and a one-pot condensation/aza-Michael
process. The synthetic utility of these compounds was explored
with the eﬃcient transformation of 5-(4′-nitrophenyl)pyrazole
α-amino acid 18 to sulfonyl fluoride derivative 31, a potential
serine protease inhibitor. The absorption and emission pro-
perties of the pyrazole derived α-amino acids were also
recorded with compounds 24 and 25 showing particularly
strong fluorescence. This part of the study has revealed the
structural features and level of conjugation required for the
generation of heterocyclic derived α-amino acids with appro-
priate emission maxima for application as fluorescent probes.
Using this information, the development of new heterocyclisa-
tion reactions of enone derived α-amino acids are currently
underway. Exploration of the use of sulfonyl fluorides such as
31 as components of peptide-based inhibitors is also being
studied. The results of these investigations will be reported in
due course.
Experimental
Reactions were performed in flame-dried glassware under a
positive atmosphere of argon. All reagents and starting
materials were obtained from commercial sources and used as
received. Dry solvents were purified using a PureSolv 500 MD
solvent purification system. Flash column chromatography
was carried out using Fisher matrix silica 60. Macherey–Nagel
aluminium-backed plates pre-coated with silica gel 60 (UV254)
were used for thin layer chromatography and were visualised
by staining with KMnO4.
1H NMR and 13C NMR spectra were
recorded on a Bruker DPX 400 spectrometer or Bruker 500
Scheme 5 Synthesis of sulfonyl ﬂuoride 31.
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spectrometer with chemical shift values in ppm relative to
TMS (δH 0.00 and δC 0.0) or residual chloroform (δH 7.28 and
δC 77.2) as standard. Assignment of
1H and 13C NMR signals
are based on two-dimensional COSY and DEPT experiments,
respectively. Mass spectra were obtained using a JEOL JMS-700
spectrometer. Infrared spectra were recorded using Golden
Gate apparatus on a JASCO FTIR 410. Melting points were
determined on a Reichert platform melting point apparatus.
Optical rotations were determined as solutions irradiating
with the sodium D line (λ = 589 nm) using an Auto pol V
polarimeter. [α]D values are given in units 10
−1 deg cm2 g−1.
Methyl (2S,5E)-2-[(benzyloxycarbonyl)amino]-4-oxo-
6-phenylhex-5-enoate (12)
To a solution of methyl (2S,5E)-4-oxo-6-phenyl-2-(tritylamino)-
hex-5-enoate (7) (1.06 g, 2.23 mmol) in dichloromethane
(45 mL) was added trifluoroacetic acid (0.33 mL, 4.50 mmol).
The reaction mixture was stirred at room temperature for 2 h
before concentrating in vacuo. The resulting residue was dis-
solved in chloroform (5 mL) and petroleum ether was added
until an orange oil formed. The solvent was then decanted oﬀ,
and the remaining oil was dissolved in dichloromethane
(30 mL) followed by the addition of N,N-diisopropylethylamine
(0.97 mL, 5.58 mmol) and benzyl chloroformate (0.48 mL,
3.35 mmol). The reaction mixture was stirred at room tempera-
ture for 1 h before diluting with water (50 mL). The mixture
was then extracted with dichloromethane (4 × 50 mL), dried
(MgSO4) and concentrated in vacuo. The resulting residue was
purified by column chromatography (elution with 50% ethyl
acetate in petroleum ether) to give methyl (2S,5E)-2-[(benzyl-
oxycarbonyl)amino]-4-oxo-6-phenylhex-5-enoate (12) as a white
solid (0.70 g, 86%). Mp 77–78 °C; νmax/cm
−1 (neat) 3333 (NH),
3059, 2951 (CH), 1734 (CvO), 1688 (CvO), 1533 (CvC), 1435,
1343, 1254, 1090, 980, 748; [α]26D +26.5 (c 1.0, CHCl3); δH
(400 MHz, CDCl3) 3.26 (1H, dd, J 17.9, 4.2 Hz, 3-HH), 3.48 (1H,
dd, J 17.9, 4.2 Hz, 3-HH), 3.75 (3H, s, OCH3), 4.68 (1H, dt, J 8.4,
4.2 Hz, 2-H), 5.12 (2H, s, OCH2Ph), 5.85 (1H, d, J 8.4 Hz, NH),
6.69 (1H, d, J 16.2 Hz, 5-H), 7.26–7.43 (8H, m, ArH), 7.51–7.59
(3H, m, 6-H and ArH); δC (101 MHz, CDCl3) 42.4 (CH2), 50.2
(CH), 52.9 (CH3) 67.2 (CH2), 125.6 (CH), 128.2 (2 × CH), 128.3
(CH), 128.6 (4 × CH), 129.2 (2 × CH), 131.0 (CH), 134.2 (C),
136.4 (C), 144.2 (CH), 156.2 (C), 171.7 (C), 197.6 (C); m/z (CI)
368.1506 (MH+. C21H22NO5 requires 368.1498), 326 (8%), 260
(23), 234 (21), 219 (18), 181 (6), 147 (17), 107 (16), 85 (100).
Methyl (2S,5E)-2-[(benzyloxycarbonyl)amino]-6-(4′-
nitrophenyl)-4-oxohex-5-enoate (13)
The reactions were performed as described for 7 using methyl
(2S,5E)-6-(4′-nitrophenyl)-4-oxo-2-(tritylamino)hex-5-enoate (8)
(0.39 g, 0.75 mmol). This gave methyl (2S,5E)-2-[(benzyloxy-
carbonyl)amino]-6-(4′-nitrophenyl)-4-oxohex-5-enoate (13) as a
yellow solid (0.24 g, 77%). Mp 73–74 °C; νmax/cm
−1 (neat) 3331
(NH), 2953 (CH), 1730 (CvO), 1686 (CvO), 1512 (CvC), 1343,
1202, 1059, 978, 860; [α]28D +20.6 (c 1.0, CHCl3); δH (400 MHz,
CDCl3) 3.30 (1H, dd, J 18.1, 4.2 Hz, 3-HH), 3.48 (1H, dd, J 18.1,
4.2 Hz, 3-HH), 3.76 (3H, s, OCH3), 4.70 (1H, dt, J 8.4, 4.2 Hz,
2-H), 5.12 (2H, s, OCH2Ph), 5.82 (1H, d, J 8.4 Hz, NH), 6.80
(1H, d, J 16.2 Hz, 5-H), 7.29–7.37 (5H, m, Ph), 7.58 (1H, d,
J 16.2 Hz, 6-H), 7.69 (2H, d, J 8.8 Hz, 2′-H and 6′-H), 8.26 (2H,
d, J 8.8 Hz, 3′-H and 5′-H); δC (101 MHz, CDCl3) 43.0 (CH2),
50.2 (CH), 53.0 (CH3), 67.3 (CH2), 124.4 (2 × CH), 128.2 (2 ×
CH), 128.4 (CH), 128.7 (2 × CH), 128.9 (CH), 129.1 (2 × CH),
136.3 (C), 140.4 (C), 140.9 (CH), 149.0 (C), 156.2 (C), 171.5 (C),
197.0 (C); m/z (CI) 413.1352 (MH+. C21H21N2O7 requires
413.1349), 383 (42%), 348 (38), 305 (30), 275 (30), 257 (23),
137 (68), 91 (68), 69 (100).
Methyl (2S,5E)-2-[(benzyloxycarbonyl)amino]-6-(4′-
methoxyphenyl)-4-oxohex-5-enoate (14)
The reactions were performed as described for 7 using methyl
(2S,5E)-6-(4′-methoxyphenyl)-4-oxo-2-(tritylamino)hex-5-enoate
(9) (0.60 g, 1.19 mmol). This gave methyl (2S,5E)-2-[(benzyloxy-
carbonyl)amino]-6-(4′-methoxyphenyl)-4-oxohex-5-enoate (14)
as a colourless oil (0.41 g, 87%). νmax/cm
−1 (neat) 3347 (NH),
2953 (CH), 1717 (CvO), 1655 (CvO), 1597 (CvC), 1510
(CvC), 1248, 1208, 1169, 1026, 816; [α]29D +30.3 (c 1.0, CHCl3);
δH (400 MHz, CDCl3) 3.23 (1H, dd, J 17.9, 4.2 Hz, 3-HH), 3.47
(1H, dd, J 17.9, 4.2 Hz, 3-HH), 3.75 (3H, s, OCH3), 3.85 (3H, s,
OCH3), 4.67 (1H, dt, J 8.5, 4.2 Hz, 2-H), 5.12 (2H, s, OCH2Ph),
5.88 (1H, d, J 8.5 Hz, NH), 6.58 (1H, d, J 16.2 Hz, 5-H), 6.92
(2H, d, J 8.8 Hz, 3′-H and 5′-H), 7.27–7.38 (5H, m, Ph), 7.49
(2H, d, J 8.8 Hz, 2′-H and 6′-H), 7.52 (1H, d, J 16.2 Hz, 6-H); δC
(101 MHz, CDCl3) 42.3 (CH2), 50.3 (CH), 52.8 (CH3), 55.6
(CH3), 67.1 (CH2), 114.6 (2 × CH), 123.4 (CH), 126.9 (C), 128.1
(2 × CH), 128.2 (CH), 128.6 (2 × CH), 130.4 (2 × CH), 136.4 (C),
144.0 (CH), 156.2 (C), 162.1 (C), 171.8 (C), 197.4 (C); m/z (EI)
397.1526 (M+. C22H23NO6 requires 397.1525), 336 (10%), 289
(19), 262 (19), 243 (45), 182 (34), 161 (100), 91 (32).
Methyl (2S,5E)-2-[(benzyloxycarbonyl)amino]-6-(naphthalen-
2′-yl)-4-oxohex-5-enoate (15)
The reactions were performed as described for 7 using methyl
(2S,5E)-6-(naphthalen-2′-yl)-4-oxo-2-(tritylamino)hex-5-enoate
(10) (0.56 g, 1.07 mmol). This gave methyl (2S,5E)-2-[(benzyl-
oxycarbonyl)amino]-6-(naphthalen-2′-yl)-4-oxohex-5-enoate (15)
as a colourless oil (0.38 g, 85%). νmax/cm
−1 (neat) 3339 (NH),
2951 (CH), 1717 (CvO), 1659 (CvO), 1505 (CvC), 1207, 1057,
976, 812; [α]28D +27.5 (c 1.0, CHCl3); δH (400 MHz, CDCl3) 3.31
(1H, dd, J 18.0, 4.2 Hz, 3-HH), 3.54 (1H, dd, J 18.0, 4.2 Hz,
3-HH), 3.77 (3H, s, OCH3), 4.71 (1H, dt, J 8.6, 4.2 Hz, 2-H), 5.13
(2H, s, OCH2Ph), 5.89 (1H, d, J 8.6 Hz, NH), 6.82 (1H, d,
J 16.2 Hz, 5-H), 7.28–7.39 (5H, m, Ph), 7.51–7.58 (2H, m, 6′-H
and 7′-H), 7.67 (1H, dd, J 8.6, 1.5 Hz, 3′-H), 7.73 (1H, d,
J 16.2 Hz, 6-H), 7.82–7.90 (3H, m, 4′-H, 5′-H and 8′-H), 7.96
(1H, br s, 1′-H); δC (101 MHz, CDCl3) 42.5 (CH2), 50.2 (CH),
52.9 (CH3), 67.2 (CH2), 123.6 (CH), 125.7 (CH), 127.0 (CH),
127.7 (CH), 127.9 (CH), 128.1 (2 × CH), 128.3 (CH), 128.6 (2 ×
CH), 128.8 (CH), 129.0 (CH), 130.9 (CH), 131.7 (C), 133.4 (C),
134.6 (C), 136.4 (C), 144.3 (CH), 156.2 (C), 171.7 (C), 197.5 (C);
m/z (CI) 418.1653 (MH+. C25H24NO5 requires 418.1654), 383
(32%), 310 (48), 275 (20), 147 (30), 107 (29).
Paper Organic & Biomolecular Chemistry
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Methyl (2S,5E)-2-[(benzyloxycarbonyl)amino]-6-(3″-
nitrobiphen-4′-yl)-4-oxohex-5-enoate (16)
The reactions were performed as described for 7 using methyl
(2S,5E)-6-(3″-nitrobiphen-4′-yl)-4-oxo-2-(tritylamino)hex-5-enoate
(11) (0.55 g, 0.92 mmol). This gave methyl (2S,5E)-2-[(benzyl-
oxycarbonyl)amino]-6-(3″-nitrobiphen-4′-yl)-4-oxohex-5-enoate
(16) as a pale yellow solid (0.38 g, 84%). Mp 102–104 °C; νmax/
cm−1 (neat) 3325 (NH), 2953 (CH), 1742 (CvO), 1683 (CvO),
1664 (CvO), 1529 (CvC), 1342, 1179, 1057, 970, 802;
[α]27D +17.2 (c 1.0, CHCl3); δH (400 MHz, CDCl3) 3.29 (1H, dd, J
18.0, 4.2 Hz, 3-HH), 3.51 (1H, dd, J 18.0, 4.2 Hz, 3-HH), 3.77
(3H, s, OCH3), 4.71 (1H, dt, J 8.5, 4.2 Hz, 2-H), 5.13 (2H, s,
OCH2Ph), 5.87 (1H, d, J 8.5 Hz, NH), 6.77 (1H, d, J 16.2 Hz,
5-H), 7.28–7.39 (5H, m, Ph), 7.61 (1H, d, J 16.2 Hz, 6-H),
7.64–7.70 (5H, m, 2′-H, 3′-H, 5′-H, 6′-H and 5″-H), 7.94 (1H,
ddd, J 7.8, 2.0, 1.0 Hz, 6″-H), 8.24 (1H, ddd, J 8.2, 2.0, 1.0 Hz,
4″-H), 8.48 (1H, t, J 2.0 Hz, 2″-H); δC (101 MHz, CDCl3) 42.6
(CH2), 50.2 (CH), 52.9 (CH3), 67.2 (CH2), 122.0 (CH), 122.8
(CH), 126.2 (CH), 127.9 (2 × CH), 128.2 (2 × CH), 128.3 (CH),
128.7 (2 × CH), 129.4 (2 × CH), 130.1 (CH), 133.0 (CH), 134.5
(C), 136.4 (C), 141.0 (C), 141.8 (C), 143.1 (CH), 149.0 (C), 156.2
(C), 171.7 (C), 197.4 (C); m/z (CI) 489.1664 (MH+. C27H25N2O7
requires 489.1662), 459 (8%), 418 (10), 381 (42), 351 (23), 338
(32), 310 (19), 275 (10), 181 (15), 147 (26), 91 (100).
Methyl (2S)-2-[(benzyloxycarbonyl)amino]-3-(1′,5′-diphenyl-1′H-
pyrazol-3′-yl)propanoate (17)
To a solution of methyl (2S,5E)-2-[(benzyloxycarbonyl)amino]-
4-oxo-6-phenylhex-5-enoate (12) (0.17 g, 0.46 mmol) in metha-
nol (4 mL) was added phenylhydrazine (0.05 mL, 0.46 mmol)
and 37% aqueous hydrochloric acid (0.02 mL). The reaction
mixture was stirred under reflux for 17 h, cooled to room temp-
erature and concentrated in vacuo. The resulting material was
diluted with ethyl acetate (10 mL) and a saturated aqueous
solution of sodium hydrogen carbonate (10 mL), extracted
with ethyl acetate (3 × 10 mL), dried (MgSO4) and concentrated
in vacuo. The resulting material was then dissolved in dichloro-
methane (30 mL) and 2,3-dichloro-5,6-dicyano-1,4-benzo-
quinone (0.10 g, 0.46 mmol) was added. After stirring at room
temperature for 2 h, the reaction mixture was concentrated
in vacuo and the resulting solid purified by column chromato-
graphy (elution with 20–30% ethyl acetate in petroleum ether),
followed by triturating with chloroform to give methyl (2S)-
2-[(benzyloxycarbonyl)amino]-3-(1′,5′-diphenyl-1′H-pyrazol-3′-yl)-
propanoate (17) as a colourless oil (0.16 g, 76%). νmax/cm
−1
(neat) 3379 (NH), 2951 (CH), 1717 (CvO), 1503 (CvC), 1375,
1207, 1051, 912, 761; [α]23D +29.2 (c 0.3, CHCl3); δH (400 MHz,
CDCl3) 3.23 (1H, dd, J 14.9, 4.9 Hz, 3-HH), 3.30 (1H, dd, J 14.9,
5.8 Hz, 3-HH), 3.77 (3H, s, OCH3), 4.71–4.79 (1H, m, 2-H), 5.10
(1H, d, J 12.2 Hz, OCHHPh), 5.14 (1H, d, J 12.2 Hz, OCHHPh),
5.77 (1H, d, J 8.4 Hz, NH), 6.27 (1H, s, 4′-H), 7.15–7.36 (15H,
m, 3 × Ph); δC (101 MHz, CDCl3) 30.7 (CH2), 52.5 (CH3), 53.6
(CH), 67.0 (CH2), 107.6 (CH), 125.2 (2 × CH), 127.4 (CH), 128.2
(3 × CH), 128.4 (CH), 128.5 (2 × CH), 128.6 (2 × CH), 128.8 (2 ×
CH), 128.9 (2 × CH), 130.5 (C), 136.5 (C), 140.0 (C), 144.0 (C),
148.3 (C), 156.1 (C), 172.1 (C); m/z (CI) 456.1925
(MH+. C27H26N3O4 requires 456.1923), 368 (9%), 348 (100), 305
(11), 257 (23), 137 (59).
Methyl (2S)-2-[(benzyloxycarbonyl)amino]-3-[5′-(4″-
nitrophenyl)-1′-phenyl-1′H-pyrazol-3′-yl]propanoate (18)
The reactions were carried out as described for 12 using
methyl (2S,5E)-2-[(benzyloxycarbonyl)amino]-6-(4′-nitrophenyl)-
4-oxohex-5-enoate (13) (0.15 g, 0.36 mmol). Purification by
column chromatography (elution with 20–40% ethyl acetate in
petroleum ether) gave methyl (2S)-2-[(benzyloxycarbonyl)-
amino]-3-[5′-(4″-nitrophenyl)-1′-phenyl-1′H-pyrazol-3′-yl]propanoate
(18) as a yellow oil (0.14 g, 76%). νmax/cm
−1 (neat) 3350 (NH),
2951 (CH), 1717 (CvO), 1597, 1502 (CvC), 1346, 1207, 1051,
972, 853; [α]23D +30.0 (c 0.3, CHCl3); δH (400 MHz, CDCl3)
3.21–3.34 (2H, m, 3-H2), 3.77 (3H, s, OCH3), 4.76 (1H, dt, J 8.2,
5.6 Hz, 2-H), 5.09 (1H, d, J 12.2 Hz, OCHHPh), 5.14 (1H, d,
J 12.2 Hz, OCHHPh), 5.72 (1H, d, J 8.2 Hz, NH), 6.41 (1H, s,
4′-H), 7.18–7.23 (2H, m, ArH), 7.29–7.38 (10H, m, 2″-H, 6″-H
and ArH), 8.14 (2H, d, J 8.7 Hz, 3″-H and 5″-H); δC (101 MHz,
CDCl3) 30.7 (CH2), 52.7 (CH3), 53.5 (CH), 67.1 (CH2), 108.8
(CH), 123.9 (2 × CH), 125.3 (2 × CH), 128.2 (CH), 128.3 (CH),
128.3 (2 × CH), 128.6 (2 × CH), 129.4 (4 × CH), 136.4 (C), 136.6
(C), 139.5 (C), 141.6 (C), 147.5 (C), 148.9 (C), 156.1 (C), 172.0
(C); m/z (EI) 500.1695 (M+. C27H24N4O6 requires 500.1696), 441
(10%), 392 (15), 349 (100), 278 (68), 232 (22), 91 (47).
Methyl (2S)-2-[(benzyloxycarbonyl)amino]-3-[5′-(4″-
methoxyphenyl)-1′-phenyl-1′H-pyrazol-3′-yl]propanoate (19)
The reactions were carried out as described for 12 using
methyl (2S,5E)-2-[(benzyloxycarbonyl)amino]-6-(4′-methoxyphen-
yl)-4-oxohex-5-enoate (14). Purification by column chromato-
graphy (elution with 20–30% ethyl acetate in petroleum ether)
gave methyl (2S)-2-[(benzyloxycarbonyl)amino]-3-[5′-(4″-
methoxyphenyl)-1′-phenyl-1′H-pyrazol-3′-yl]propanoate (19) as
a colourless oil (0.07 g, 75%). νmax/cm
−1 (neat) 3339 (NH), 2951
(CH), 1717 (CvO), 1506 (CvC), 1498, 1436, 1248, 1176, 1027,
835; [α]26D +10.6 (c 0.5, CHCl3); δH (400 MHz, CDCl3) 3.23 (1H,
dd, J 14.8, 4.9 Hz, 3-HH), 3.30 (1H, dd, J 14.8, 5.7 Hz, 3-HH),
3.78 (3H, s, OCH3), 3.81 (3H, s, OCH3), 4.72–4.78 (1H, m, 2-H),
5.11 (1H, d, J 12.3 Hz, OCHHPh), 5.15 (1H, d, J 12.3 Hz,
OCHHPh), 5.80 (1H, d, J 8.3 Hz, NH), 6.22 (1H, s, 4′-H), 6.82
(2H, d, J 8.8 Hz, 3″-H and 5″-H), 7.11 (2H, d, J 8.8 Hz, 2″-H and
6″-H), 7.22–7.38 (10H, m, 2 × Ph); δC (101 MHz, CDCl3) 30.8
(CH2), 52.6 (CH3), 53.6 (CH), 55.4 (CH3), 67.0 (CH2), 107.1
(CH), 114.0 (2 × CH), 122.9 (C), 125.2 (2 × CH), 127.3 (CH),
128.2 (3 × CH), 128.6 (2 × CH), 128.9 (2 × CH), 130.1 (2 × CH),
136.5 (C), 140.1 (C), 143.9 (C), 148.2 (C), 156.1 (C), 159.7 (C),
172.2 (C); m/z (EI) 485.1961 (M+. C28H27N3O5 requires 485.1951),
426 (31%), 377 (27), 334 (100), 318 (17), 263 (61), 199 (18),
91 (33).
Methyl (2S)-2-[(benzyloxycarbonyl)amino]-3-[5′-(naphthalen-
2″-yl)-1′-phenyl-1′H-pyrazol-3′-yl]propanoate (20)
The reactions were carried out as described for 12 using
methyl (2S,5E)-2-[(benzyloxycarbonyl)amino]-6-(naphthalen-
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2′-yl)-4-oxohex-5-enoate (15) (0.15 g, 0.36 mmol). Purification
by column chromatography (elution with 20% ethyl acetate in
petroleum ether) gave methyl (2S)-2-[(benzyloxycarbonyl)-
amino]-3-[5′-(naphthalen-2″-yl)-1′-phenyl-1′H-pyrazol-3′-yl]pro-
panoate (20) as a white solid (0.13 g, 73%). Mp 66–67 °C;
νmax/cm
−1 (neat) 3341 (NH), 2924 (CH), 1719 (CvO), 1597,
1499 (CvC), 1207, 1047, 818, 748; [α]25D +14.0 (c 0.2, CHCl3);
δH (400 MHz, CDCl3) 3.27 (1H, dd, J 15.0, 4.7 Hz, 3-HH), 3.33
(1H, dd, J 15.0, 5.7 Hz, 3-HH), 3.79 (3H, s, OCH3), 4.73–4.82
(1H, m, 2-H), 5.10 (1H, d, J 12.3 Hz, OCHHPh), 5.15 (1H, d,
J 12.3 Hz, OCHHPh), 5.81 (1H, d, J 8.1 Hz, NH), 6.38 (1H, s,
4′-H), 7.19 (1H, dd, J 8.5, 1.6 Hz, 3″-H), 7.24–7.38 (10H, m, 2 ×
Ph), 7.46–7.53 (2H, m, 6″-H and 7″-H), 7.69–7.84 (4H, m,
1″-H, 4″-H, 5″-H and 8″-H); δC (101 MHz, CDCl3) 30.8 (CH2),
52.7 (CH3), 53.6 (CH), 67.1 (CH2), 108.0 (CH), 125.2 (2 × CH),
126.4 (CH), 126.7 (CH), 126.8 (CH), 127.5 (CH), 127.9 (CH),
127.9 (C), 128.1 (CH), 128.2 (CH), 128.2 (3 × CH), 128.3 (CH),
128.6 (2 × CH), 129.1 (2 × CH), 132.9 (C), 133.2 (C), 136.5 (C),
141.1 (C), 144.0 (C), 148.5 (C), 156.2 (C), 172.1 (C); m/z (EI)
505.2012 (M+. C31H27N3O4 requires 505.2002), 446 (10%), 397
(55), 354 (45), 338 (20), 283 (100), 215 (10), 108 (13), 91 (27).
Methyl (2S)-2-[(benzyloxycarbonyl)amino]-3-[5′-(3′′′-
nitrobiphen-4″-yl)-1′-phenyl-1′H-pyrazol-3′-yl]propanoate (21)
The reactions were carried out as described for 12 using
methyl (2S,5E)-2-[(benzyloxycarbonyl)amino]-6-(3″-nitrobiphen-
4′-yl)-4-oxohex-5-enoate (16) (0.20 g, 0.41 mmol). Purification
by column chromatography (elution with 20% ethyl acetate in
petroleum ether) gave methyl (2S)-2-[(benzyloxycarbonyl)-
amino]-3-[5′-(3′′′-nitrobiphen-4″-yl)-1′-phenyl-1′H-pyrazol-3′-yl]-
propanoate (21) as a yellow oil (0.20 g, 84%). νmax/cm
−1 (neat)
3359 (NH), 2922 (CH), 1716 (CvO), 1508 (CvC), 1500, 1348,
1207, 1052, 803, 727; [α]23D +20.5 (c 0.4, CHCl3); δH (400 MHz,
CDCl3) 3.26 (1H, dd, J 15.0, 4.9 Hz, 3-HH), 3.32 (1H, dd, J 15.0,
5.6 Hz, 3-HH), 3.79 (3H, s, OCH3), 4.73–4.81 (1H, m, 2-H), 5.11
(1H, d, J 12.3 Hz, OCHHPh), 5.15 (1H, d, J 12.3 Hz, OCHHPh),
5.78 (1H, d, J 8.3 Hz, NH), 6.36 (1H, s, 4′-H), 7.26–7.39 (12H,
m, 2″-H, 6″-H and 2 × Ph), 7.56 (2H, d, J 8.3 Hz, 3″-H and
5″-H), 7.62 (1H, t, J 8.0 Hz, 5′′′-H), 7.88–7.93 (1H, m, 6′′′-H),
8.21 (1H, ddd, J 8.0, 1.9, 0.8 Hz, 4′′′-H), 8.44 (1H, t, J 1.9 Hz,
2′′′-H); δC (101 MHz, CDCl3) 30.8 (CH2), 52.7 (CH3), 53.6 (CH),
67.1 (CH2), 107.9 (CH), 122.0 (CH), 122.5 (CH), 125.3 (2 × CH),
127.3 (2 × CH), 127.8 (CH), 128.3 (3 × CH), 128.7 (2 × CH),
129.2 (2 × CH), 129.5 (2 × CH), 130.0 (CH), 130.7 (C), 133.0
(CH), 136.5 (C), 138.6 (C), 140.1 (C), 142.0 (C), 143.3 (C), 148.5
(C), 148.9 (C), 156.1 (C), 172.2 (C); m/z (EI) 576.2007
(M+. C33H28N4O6 requires 576.2009), 468 (45%), 425 (15), 409
(26), 381 (17), 354 (100), 308 (17), 202 (6), 159 (9), 77 (18).
(2S)-2-Amino-3-(1′,5′-diphenyl-1′H-pyrazol-3′-yl)propanoic acid
hydrochloride (22)
To a solution of methyl (2S)-2-[(benzyloxycarbonyl)amino]-
3-(1′,5′-diphenyl-1′H-pyrazol-3′-yl)propanoate (17) (0.09 g,
0.19 mmol) in methanol and water (5 mL, 7 : 3) was added
cesium carbonate (0.08 g, 0.25 mmol). The reaction mixture
was stirred at room temperature for 16 h before concentrating
in vacuo. The resulting residue was dissolved in water (10 mL),
acidified to pH 1 with 1.0 M aqueous hydrochloric acid,
extracted with dichloromethane (3 × 10 mL), dried (MgSO4)
and concentrated in vacuo. The resulting residue was sus-
pended in 6.0 M aqueous hydrochloric acid (5 mL) and the
mixture stirred under reflux for 24 h. The mixture was cooled
and concentrated in vacuo. Trituration with diethyl ether gave
(2S)-2-amino-3-(1′,5′-diphenyl-1′H-pyrazol-3′-yl)propanoic acid
hydrochloride (22) as a white foam (0.05 g, 88%). νmax/cm
−1
(neat) 3380 (NH), 3058 (CH), 1631 (CvO), 1596, 1503 (CvC),
1424, 1375, 1112, 761; [α]28D −25.8 (c 0.4, MeOH); δH (400 MHz,
CD3OD) 3.20–3.45 (2H, m, 3-H2), 4.02 (1H, br s, 2-H), 6.53 (1H,
s, 4′-H), 7.17–7.40 (10H, m, 2 × Ph); δH (126 MHz, CD3OD) 30.3
(CH2), 55.7 (CH), 108.7 (CH), 126.7 (2 × CH), 129.0 (CH), 129.6
(3 × CH), 129.8 (2 × CH), 130.1 (2 × CH), 131.5 (C), 141.3 (C),
145.9 (C), 150.0 (C), 173.8 (C); m/z (ESI) 308.1382
(MH+. C18H18N3O2 requires 308.1394).
(2S)-2-Amino-3-[5′-(4″-methoxyphenyl)-1′-phenyl-1′H-pyrazol-
3′-yl]propanoic acid hydrochloride (23)
The reactions were carried out as described for 17 using
methyl (2S)-2-[(benzyloxycarbonyl)amino]-3-[5′-(4″-methoxy-
phenyl)-1′-phenyl-1′H-pyrazol-3′-yl]propanoate (19) (0.07 g,
0.14 mmol). This gave (2S)-2-amino-3-[5′-(4″-methoxyphenyl)-
1′-phenyl-1′H-pyrazol-3′-yl]propanoic acid hydrochloride (23) as
a white foam (0.04 g, 79%). νmax/cm
−1 (neat) 3359 (NH), 2921
(CH), 1729 (CvO), 1611, 1506 (CvC), 1499, 1437, 1151, 834;
[α]28D −25.0 (c 0.2, CHCl3); δH (500 MHz, CD3OD) 3.32 (1H, dd,
J 16.0, 7.5 Hz, 3-HH), 3.42 (1H, dd, J 16.0, 4.4 Hz, 3-HH), 3.78
(3H, s, OCH3), 4.38–4.43 (1H, m, 2-H), 6.46 (1H, s, 4′-H), 6.86
(2H, d, J 8.7 Hz, 3″-H and 5″-H), 7.14 (2H, d, J 8.7 Hz, 2″-H and
6″-H), 7.27–7.42 (5H, m, Ph); δC (126 MHz, CD3OD) 29.6 (CH2),
53.7 (CH), 55.9 (CH3), 108.0 (CH), 115.1 (2 × CH), 123.6 (C),
126.6 (2 × CH), 129.0 (CH), 130.1 (2 × CH), 131.2 (2 × CH),
141.3 (C), 146.3 (C), 148.3 (C), 161.6 (C), 171.0 (C); m/z (ESI)
338.1489 (MH+. C19H20N3O3 requires 338.1499).
(2S)-2-Amino-3-[5′-(naphthalen-2″-yl)-1′-phenyl-1′H-pyrazol-
3′-yl]propanoic acid hydrochloride (24)
The reactions were carried out as described for 17 using (2S)-2-
[(benzyloxycarbonyl)amino]-3-[5′-(naphthalen-2″-yl)-1′-phenyl-
1′H-pyrazol-3′-yl]propanoate (20) (0.03 g, 0.06 mmol). This gave
(2S)-2-amino-3-[5′-(naphthalen-2″-yl)-1′-phenyl-1′H-pyrazol-3′-yl]-
propanoic acid hydrochloride (24) as an oﬀ-white foam (0.02 g,
83%). νmax/cm
−1 (neat) 3366 (NH), 2922 (CH), 1739 (CvO),
1596 (CvC), 1498, 1205, 1081, 819, 752; [α]28D −33.7 (c 0.3,
MeOH); δH (400 MHz, CD3OD) 3.40 (1H, dd, J 15.8, 7.3 Hz,
3-HH), 3.49 (1H, br d, J 15.8 Hz, 3-HH), 4.44–4.51 (1H, m, 2-H),
6.70 (1H, s, 4′-H), 7.25 (1H, br d, J 8.2 Hz, 3″-H), 7.32–7.42 (5H,
m, Ph), 7.46–7.54 (2H, m, 6″-H and 7″-H), 7.72–7.87 (4H, m,
1″-H, 4″-H, 5″-H and 8″-H); δC (101 MHz, CD3OD) 29.6 (CH2),
53.5 (CH), 109.0 (CH), 126.7 (2 × CH), 127.0 (CH), 127.8 (CH),
128.1 (CH), 128.5 (C), 128.7 (CH), 129.2 (CH), 129.3 (2 × CH),
129.3 (CH) 130.2 (2 × CH), 134.4 (2 × C), 140.9 (C), 146.3 (C),
148.4 (C), 171.0 (C); m/z (ESI) 358.1541 (MH+. C22H20N3O2
requires 358.1550).
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(2S)-2-Amino-3-[5′-(4″-nitrophenyl)-1′-phenyl-1′H-pyrazol-3′-yl]-
propanoic acid hydrochloride (25)
To a solution of methyl (2S)-2-[(benzyloxycarbonyl)amino]-3-
[5′-(4″-nitrophenyl)-1′-phenyl-1′H-pyrazol-3′-yl]propanoate (18)
(0.08 g, 0.16 mmol) in methanol (0.5 mL) was added 6.0 M
aqueous hydrochloric acid (4.5 mL). The reaction mixture was
then stirred under reflux for 48 h. After cooling to room temp-
erature, the mixture was concentrated in vacuo and triturated
with diethyl ether to give (2S)-2-amino-3-[5′-(4″-nitrophenyl)-1′-
phenyl-1′H-pyrazol-3′-yl]propanoic acid hydrochloride (25) as a
pale yellow foam (0.06 g, 97%). νmax/cm
−1 (neat) 3400 (NH),
2918 (CH), 2850, 1744 (CvO), 1596 (CvC), 1515, 1502, 1344,
1255, 1080, 854; [α]27D −16.0 (c 0.3, MeOH); δH (400 MHz,
CD3OD) 3.33–3.51 (2H, m, 3-H2), 4.41–4.48 (1H, m, 2-H), 6.73
(1H, s, 4′-H), 7.29–7.46 (5H, m, Ph), 7.48 (2H, d, J 7.7 Hz, 2″-H
and 6″-H), 8.19 (2H, d, J 7.7 Hz, 3″-H and 5″-H); δC (101 MHz,
CD3OD) 29.6 (CH2), 53.5 (CH), 109.9 (CH), 124.7 (2 × CH),
126.8 (2 × CH), 129.6 (CH), 130.4 (2 × CH), 130.8 (2 × CH),
137.5 (C), 140.6 (C), 143.8 (C), 148.7 (C), 148.9 (C), 170.9 (C);
m/z (ESI) 351.1082 ([M − H]−. C18H15N4O4 requires 351.1099).
(2S)-2-Amino-3-[5′-(3′′′-nitrobiphen-4″-yl)-1′-phenyl-1′H-pyrazol-
3′-yl]propanoic acid hydrochloride (26)
The reaction was carried out as described for 18 using methyl
(2S)-2-[(benzyloxycarbonyl)amino]-3-[5′-(3′′′-nitrobiphen-4″-yl)-
1′-phenyl-1′H-pyrazol-3′-yl]propanoate (21) (0.15 g, 0.26 mmol).
This gave (2S)-2-amino-3-[5′-(3′′′-nitrobiphen-4″-yl)-1′-phenyl-
1′H-pyrazol-3′-yl]propanoic acid hydrochloride (26) as an oﬀ-
white foam (0.12 g, 98%). νmax/cm
−1 (neat) 3026 (NH), 2861
(CH), 1731 (CvO), 1526 (CvC), 1500, 1347, 1198, 973, 803,
726; [α]28D −38.3 (c 0.3, MeOH); δH (400 MHz, CD3OD) 3.37 (1H,
dd, J 15.8, 7.5 Hz, 3-HH), 3.46 (1H, dd, J 15.8, 4.6 Hz, 3-HH),
4.45 (1H, dd, J 7.5, 4.6 Hz, 2-H), 6.64 (1H, s, 4′-H), 7.33–7.45
(7H, m, 2″-H, 6″-H and Ph), 7.66–7.73 (3H, m, 3″-H, 5″-H and
5′′′-H), 8.04 (1H, ddd, J 7.8, 2.0, 0.9 Hz, 6′′′-H), 8.23 (1H, ddd,
J 8.2, 2.0, 0.9 Hz, 4′′′-H), 8.46 (1H, t, J 2.0 Hz, 2′′′-H); δC
(101 MHz, CD3OD) 29.6 (CH2), 53.6 (CH), 108.8 (CH), 122.5
(CH), 123.4 (CH), 126.8 (2 × CH), 128.4 (2 × CH), 129.3 (CH),
130.3 (2 × CH), 130.6 (2 × CH), 131.3 (CH), 131.5 (C), 134.1
(CH), 140.2 (C), 141.1 (C), 143.0 (C), 145.5 (C), 148.5 (C), 150.3
(C), 171.0 (C); m/z (ESI) 429.1545 (MH+. C24H21N4O4 requires
429.1557).
(2S)-2-[(Benzyloxycarbonyl)amino]-3-[5′-(4″-nitrophenyl)-
1′-phenyl-1′H-pyrazol-3′-yl]propan-1-ol (27)
Methyl (2S)-2-[(benzyloxycarbonyl)amino]-3-[5′-(4″-nitro-
phenyl)-1′-phenyl-1′H-pyrazol-3′-yl]propanoate (18) (2.90 g,
5.79 mmol) was dissolved in THF (25 mL) under an atmos-
phere of argon at room temperature. Lithium chloride (0.61 g,
14.5 mmol) was added, followed by sodium borohydride
(0.55 g, 14.5 mmol, 2.50 eq.) and the mixture was stirred for
0.1 h. Ethanol (34 mL) was added and the cloudy mixture
stirred for 7 h at room temperature. The reaction mixture was
cooled to 0 °C and quenched with a saturated solution of
ammonium chloride (28 mL) and water (81 mL). The solution
was extracted with ethyl acetate (3 × 100 mL). The combined
organic phases were dried (MgSO4) and the solvent removed
in vacuo. Purification by column chromatography (gradient
elution with ethyl acetate in petroleum ether, 1 : 1 to 7 : 3)
gave (2S)-2-[(benzyloxycarbonyl)amino]-3-[5′-(4″-nitrophenyl)-
1′-phenyl-1′H-pyrazol-3′-yl]propan-1-ol (27) as a colourless solid
(2.60 g, 95%). νmax/cm
−1 (neat) 3335 (OH), 2934 (CH), 1697
(CvO), 1597, 1518, 1502, 1346, 1219, 853, 752, 696; [α]21D +11.5
(c 0.9, CDCl3); δH (500 MHz, CDCl3) 2.94 (1H, dd, J 14.8,
6.1 Hz, 3-HH), 3.00 (1H, dd, J 14.8, 6.6 Hz, 3-HH), 3.06 (1H, br
s, OH), 3.62–3.76 (2H, m, 1-H2), 3.96–4.06 (1H, m, 2-H), 5.02
(1H, d, J 12.3 Hz, OCHHPh), 5.05 (1H, d, J 12.3 Hz, OCHHPh),
5.37 (1H, d, J 7.0 Hz, NH), 6.42 (1H, s, 4′-H), 7.12–7.17 (2H, m,
2″-H and 6″-H), 7.20–7.33 (10H, m, 2 × Ph), 8.05–8.09 (2H, m,
3″-H and 5″-H); δC (126 MHz, CDCl3) 30.1 (CH2), 52.2 (CH),
64.6 (CH2), 66.8 (CH2), 109.1 (CH), 123.8 (2 × CH), 125.3 (2 ×
CH), 128.1 (CH), 128.2 (CH), 128.3 (2 × CH), 128.5 (2 × CH),
129.2 (2 × CH), 129.4 (2 × CH), 136.4 (C), 136.4 (C), 139.2 (C),
141.6 (C), 147.4 (C), 150.2 (C), 156.5 (C); m/z (ESI) 495.1632
(MNa+. C26H24N4NaO5 requires 495.1639).
(2S)-2-[(Benzyloxycarbonyl)amino]-1-methanesulfonate-3-[5′-
(4″-nitrophenyl)-1′-phenyl-1′H-pyrazol-3′-yl]propane (28)
(2S)-2-[(Benzyloxycarbonyl)amino]-3-[5′-(4″-nitrophenyl)-1′-phenyl-
1′H-pyrazol-3′-yl]propan-1-ol (27) (2.56 g, 5.42 mmol) was
dissolved in dichloromethane (64 mL) and cooled to 0 °C.
Methanesulfonyl chloride (0.63 mL, 8.13 mmol) and triethyl-
amine (1.21 mL, 8.67 mmol) were added dropwise and the
reactionmixture stirred at room temperature for 0.5 h. Dichloro-
methane (50 mL) was added to the reaction mixture, which
was then washed with 1 M aqueous potassium hydrogensulfo-
nate (100 mL), water (100 mL), brine (100 mL) and dried
(MgSO4). The solvent was removed in vacuo and gave 28 as a
colourless solid (2.72 g, 92%). νmax/cm
−1 (neat) 3270 (NH),
3028 (CH), 1713 (CvO), 1597, 1518, 1502, 1346, 1172, 963,
750, 696; [α]23D −7.1 (c 0.8, CDCl3); δH (400 MHz, CDCl3) 2.94
(3H, s, SO2CH3), 3.00 (2H, d, J 5.1 Hz, 3-H2), 4.22–4.33 (3H, m,
1-H2 and 2-H), 5.04 (2H, s, OCH2Ph), 5.41 (1H, br s, NH), 6.44
(1H, s, 4′-H), 7.13–7.18 (2H, m, 2″-H and 6″-H), 7.21–7.33 (10H,
m, 2 × Ph), 8.05–8.12 (2H, m, 3″-H and 5″-H); δC (101 MHz,
CDCl3) 29.4 (CH2), 37.4 (CH3), 49.8 (CH), 67.0 (CH2), 69.6
(CH2), 109.0 (CH), 123.8 (2 × CH), 125.3 (2 × CH), 128.1 (2 ×
CH), 128.3 (2 × CH), 128.6 (2 × CH), 129.3 (2 × CH), 129.3 (2 ×
CH), 136.3 (C), 136.4 (C), 139.3 (C), 141.7 (C), 147.4 (C), 149.0
(C), 155.8 (C); m/z (ESI) 573.1389 (MNa+. C27H26N4NaO7S
requires 573.1414).
(2S)-2-[(Benzyloxycarbonyl)amino]-3-[5′-(4″-nitrophenyl)-
1′-phenyl-1′H-pyrazol-3′-yl]-1-thioacetylpropane (29)
Thioacetic acid (0.78 mL, 10.9 mmol) was added to a suspen-
sion of cesium carbonate (1.77 g, 5.43 mmol) in DMF (5 mL).
This solution was added to (2S)-2-[(benzyloxycarbonyl)amino]-
1-methanesulfonate-3-[5′-(4″-nitrophenyl)-1′-phenyl-1′H-pyrazol-
3′-yl]propane (28) (2.72 g, 4.94 mmol) in DMF (10 mL) under
an atmosphere of argon. The reaction mixture was stirred over-
night in the dark at room temperature. Ethyl acetate (50 mL)
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and water (50 mL) were added and the organic layer was
washed with 1 M aqueous potassium hydrogensulfate
(100 mL), 1 M aqueous sodium hydrogencarbonate (100 mL),
brine (100 mL) and dried (MgSO4). The solvents were evapor-
ated and the crude product purified by column chromato-
graphy (30% ethyl acetate in petroleum ether). (2S)-
2-[(Benzyloxycarbonyl)amino]-3-[5′-(4″-nitrophenyl)-1′-phenyl-
1′H-pyrazol-3′-yl]-1-thioacetylpropane (29) was obtained as a
slightly orange-brownish solid (2.22 g, 85%). νmax/cm
−1 (neat)
3355 (NH), 3075 (CH), 1694 (CvO), 1597, 1518, 1503, 1347,
1252, 1133, 853, 754; [α]21D −3.2 (c 0.7, CDCl3); δH (500 MHz,
CDCl3) 2.27 (3H, s, COCH3), 2.94 (2H, d, J 6.2 Hz, 3-H2),
3.06–3.18 (2H, m, 1-H2), 4.07–4.18 (1H, m, 2-H), 5.01 (2H, s,
OCH2Ph), 5.41 (1H, d, J 8.2 Hz, NH), 6.42 (1H, s, 4′-H),
7.14–7.18 (2H, m, 2″-H and 6″-H), 7.20–7.33 (10H, m, 2 × Ph),
8.04–8.10 (2H, m, 3″-H and 5″-H); δC (101 MHz, CDCl3) 30.6
(CH3), 32.5 (CH2), 33.1 (CH2), 51.0 (CH), 66.6 (CH2), 108.9
(CH), 123.8 (2 × CH), 125.3 (2 × CH), 128.0 (CH), 128.1 (CH),
128.1 (2 × CH), 128.5 (2 × CH), 129.2 (2 × CH), 129.3 (2 × CH),
136.6 (C), 139.4 (C), 141.5 (2 × C), 147.3 (C), 149.7 (C), 156.0
(C), 195.7 (C); m/z (ESI) 553.1502 (MNa+. C28H26N4NaO5S
requires 553.1516).
(2S)-2-[(Benzyloxycarbonyl)amino]-1-fluorosulfonyl-3-[5′-(4″-
nitrophenyl)-1′-phenyl-1′H-pyrazol-3′-yl]propane (31)
(2S)-2-[(Benzyloxycarbonyl)amino]-3-[5′-(4″-nitrophenyl)-1′-phenyl-
1′H-pyrazol-3′-yl]-1-thioacetylpropane (29) (2.22 g, 4.18 mmol)
was dissolved in acetic acid (15 mL) and 30% hydrogen per-
oxide (4.8 mL) was added and stirred overnight at room temp-
erature. Sodium acetate (0.34 g, 4.18 mmol) was added and the
mixture stirred for 1 h. DMF (5 mL) was added and the solu-
tion was partially concentrated in vacuo. This procedure was
repeated three more times until the DMF was removed comple-
tely. After co-evaporation twice with water and three times with
toluene, sodium (2S)-2-[(benzyloxycarbonyl)amino]-3-[5′-(4″-
nitrophenyl)-1′-phenyl-1′H-pyrazol-3′-yl]propane-1-sulfonate was
obtained as a yellow solid (2.37 g, 100%). A quantity of (2S)-2-
[(benzyloxycarbonyl)amino]-3-[5′-(4″-nitrophenyl)-1′-phenyl-1′H-
pyrazol-3′-yl]propane-1-sulfonate (0.20 g, 0.36 mmol) was dis-
solved in dichloromethane (15 mL) under an atmosphere of
argon and XtalFluor-M® (30) (0.16 g, 644 µmol) and triethyl-
amine trihydrofluoride (2.5 µL, 15.4 µmol) were added. The
reaction mixture was heated under reflux for 20 h. Silica was
added to quench the reaction and the solvent removed
in vacuo. Purification by column chromatography (40% ethyl
acetate in petroleum ether) gave (2S)-2-[(benzyloxycarbonyl)-
amino]-1-fluorosulfonyl-3-[5′-(4″-nitrophenyl)-1′-phenyl-1′H-pyrazol-
3′-yl]propane (31) as a yellow solid (0.123 g, 64%). νmax/cm
−1
(neat) 3337 (NH), 2930 (CH), 1699 (CvO), 1598, 1538, 1515,
1407, 1388, 1347, 1265, 1195, 1050, 973, 854; [α]20D +5.0 (c 1.0,
CDCl3); δH (400 MHz, CDCl3) 3.10–3.24 (2H, m, 3-H2), 3.70
(1H, dt, J 14.6, 5.7 Hz, 1-HH), 3.91 (1H, dd, J 14.6, 5.7 Hz,
1-HH), 4.52–4.63 (1H, m, 2-H), 5.06 (2H, s, OCH2Ph), 5.73 (1H,
d, J 8.0 Hz, NH), 6.43 (1H, s, 4′-H), 7.13–7.18 (2H, m, 2″-H and
6″-H), 7.23–7.37 (10H, m, 2 × Ph), 8.06–8.12 (2H, m, 3″-H and
5″-H); δC (126 MHz, CDCl3) 31.2 (CH2), 46.9 (CH), 53.2 (CH2, d,
JC–S–F 15.1 Hz), 67.2 (CH2), 109.3 (CH), 123.8 (2 × CH), 125.2
(2 × CH), 128.2 (2 × CH), 128.3 (CH), 128.4 (CH), 128.6 (2 ×
CH), 129.3 (2 × CH), 129.4 (2 × CH), 136.0 (C), 136.1 (C), 139.1
(C), 141.8 (C), 147.5 (C), 148.4 (C), 155.4 (C); δF (377 MHz,
CDCl3) 60.2 (1F, s, SO2F); m/z (ESI) 561.1192 (MNa
+.
C26H23FN4NaO6S requires 561.1215).
Acknowledgements
Financial support from SINAPSE (studentship to LG), the
University of Glasgow (studentship to RA) and the EPSRC
(studentship to AHH, EP/K503058) is gratefully acknowledged.
Notes and references
1 For reviews see: (a) I. Wagner and H. Musso, Angew. Chem.,
Int. Ed. Engl., 1983, 22, 816; (b) J. P. Greenstein and
M. Winitz, in Chemistry of the Amino Acids, R. E. Krieger,
FL, 1984, vol. 1–3; (c) Chemistry and Biochemistry of the
Amino Acids, ed. G. C. Barrett, Chapman and Hall, London,
1985; (d) M. J. O’Donnell, α-Amino Acid Synthesis, Tetra-
hedron, 1988, 44, 5253; (e) R. M. Williams, Synthesis of Opti-
cally Active α-Amino Acids, Pergamon Press, Oxford, 1989,
vol. 7.
2 (a) Y. Ohfune, Acc. Chem. Res., 1992, 25, 360;
(b) A. Sutherland and C. L. Willis, Nat. Prod. Rep., 2000, 17,
621; (c) D. A. Dougherty, Curr. Opin. Chem. Biol., 2000, 4,
645; (d) Y. Ohfune and T. Shinada, Eur. J. Org. Chem., 2005,
5127; (e) H. Vogt and S. Bräse, Org. Biomol. Chem., 2007, 5,
406; (f ) R. Smits, C. D. Cadicamo, K. Burger and B. Koksch,
Chem. Soc. Rev., 2008, 37, 1727; (g) M. Mortensen,
R. Husmann, E. Veri and C. Bolm, Chem. Soc. Rev., 2009,
38, 1002; (h) K. Lang and J. W. Chin, Chem. Rev., 2014, 114,
4764.
3 For example, see: (a) C. J. Easton, Chem. Rev., 1997, 97, 53;
(b) C. Nájera and J. M. Sansano, Chem. Rev., 2007, 107,
4584; (c) A. F. M. Noisier and M. A. Brimble, Chem. Rev.,
2014, 114, 8775.
4 (a) P. Kolar, A. Petrič and M. Tišler, J. Heterocycl. Chem.,
1997, 34, 1067; (b) P. Singh, K. Samanta, S. K. Das and
G. Panda, Org. Biomol. Chem., 2014, 12, 6297.
5 (a) S. Shinano and T. Kaya, J. Agric. Chem. Soc. Jpn., 1957,
31, 759; (b) C. N. Farthing, J. E. Baldwin, A. T. Russell,
C. J. Schofield and A. C. Spivey, Tetrahedron Lett., 1996, 37,
5225.
6 C. G. Jørgensen, H. Bräuner-Osborne, B. Nielsen, J. Kehler,
R. P. Clausen, P. Krogsgaard-Larsen and U. Madsen, Bioorg.
Med. Chem., 2007, 15, 3524.
7 (a) P. Conti, G. Grazioso, S. J. Di Ventimiglia, A. Pinto,
G. Roda, U. Madsen, H. Bräuner-Osborne, B. Nielsen,
C. Costagli and A. Galli, Chem. Biodiversity, 2005, 2, 748;
(b) P. Conti, A. Pinto, L. Tamborini, U. Madsen, B. Nielsen,
H. Bräuner-Osborne, K. B. Hansen, E. Landucci,
D. E. Pellegrini-Giampietro, G. De Sarro, E. D. Di Paola and
C. De Micheli, ChemMedChem, 2010, 5, 1465.
Paper Organic & Biomolecular Chemistry
4522 | Org. Biomol. Chem., 2015, 13, 4514–4523 This journal is © The Royal Society of Chemistry 2015
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 1
0 
M
ar
ch
 2
01
5.
 D
ow
nl
oa
de
d 
on
 2
5/
05
/2
01
5 
16
:0
3:
40
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n 
3.
0 
U
np
or
te
d 
Li
ce
nc
e.
View Article Online
8 M. D. Joksović, V. Marković, Z. D. Juranić, T. Stanojković,
L. S. Jovanović, I. S. Damljanović, K. M. Szécsényi,
N. Todorović, S. Trifunović and R. D. Vukićević, J. Organo-
met. Chem., 2009, 694, 3935.
9 (a) L. De Luca, M. Falorni, G. Giacomelli and A. Porcheddu,
Tetrahedron Lett., 1999, 40, 8701; (b) L. De Luca,
G. Giacomelli, A. Porcheddu, A. M. Spanedda and
M. Falorni, Synthesis, 2000, 1295.
10 For the synthesis of optically active pyrazole containing
α-amino acids, see: (a) L. Wei and W. D. Lubell,
Can. J. Chem., 2001, 79, 94; (b) U. Ursic, D. Bevk, S. Pirc,
L. Pezdirc, B. Stanovnik and J. Svete, Synthesis, 2006, 2376.
11 For the synthesis of racemic α-amino acids bearing a
pyrazole side-chain, see: (a) A. Prešeren, J. Svete and
B. Stanovnik, J. Heterocycl. Chem., 1999, 36, 799; (b) A. de la
Hoz, A. Díaz-Ortiz, M. V. Gómez, J. A. Mayoral, A. Moreno,
A. M. Sánchez-Migallón and E. Vázquez, Tetrahedron, 2001,
57, 5421; (c) P. Calí and M. Begtrup, Tetrahedron, 2002, 58,
1595; (d) L. Vraničar, F. Požgan, S. Polanc and M. Kočevar,
Amino Acids, 2003, 24, 273; (e) A. Heim-Riether, Synthesis,
2008, 883.
12 L. S. Fowler, D. Ellis and A. Sutherland, Org. Biomol. Chem.,
2009, 7, 4309.
13 (a) L. S. Fowler, L. H. Thomas, D. Ellis and A. Sutherland,
Chem. Commun., 2011, 47, 6569; (b) M. Daly, A. A. Cant,
L. S. Fowler, G. L. Simpson, H. M. Senn and A. Sutherland,
J. Org. Chem., 2012, 77, 10001.
14 D. E. Rudisill and J. P. Whitten, Synthesis, 1994, 851.
15 C. M. Reid, K. N. Fanning, L. S. Fowler and A. Sutherland,
Tetrahedron, 2015, 71, 245.
16 For reviews of 2-pyrazoline formation from enones, see:
(a) A. Lévai, J. Heterocycl. Chem., 2002, 39, 1; (b) A. Lévai,
J. Heterocycl. Chem., 2004, 41, 299.
17 S. Duggineni, D. Sawant, B. Saha and B. Kundu, Tetra-
hedron, 2006, 62, 3228.
18 For reviews on fluorescent α-amino acids, see:
(a) A. R. Katritzky and T. Narindoshvili, Org. Biomol. Chem.,
2009, 7, 627; (b) M. S. T. Gonçalves, Chem. Rev., 2009, 109,
190.
19 G. D. Fasman, Handbook of Biochemistry and
Molecular Biology, Proteins, CRC, Boca Raton, Florida, 1976,
vol. I.
20 The 3-nitrobiphenyl analogue 26 was found to have a emis-
sion maximum at 434 nm, which is potentially most suit-
able for application in proteins and peptides containing
fluorescent proteinogenic α-amino acids such as tyrosine
and tryptophan. However, 26 produced the weakest emis-
sion maximum of the five pyrazole α-amino acids and so
was not considered further.
21 A. J. Brouwer, T. Ceylan, T. van der Linden and
R. M. J. Liskamp, Tetrahedron Lett., 2009, 50, 3391.
22 (a) A. J. Brouwer, T. Ceylan, A. M. Jonker, T. van der Linden
and R. M. J. Liskamp, Bioorg. Med. Chem., 2011, 19, 2397;
(b) A. J. Brouwer, A. Jonker, P. Werkhoven, E. Kuo, N. Li,
N. Gallasteugi, J. Kemmink, B. I. Florea, M. Groll,
H. S. Overkleeft and R. M. J. Liskamp, J. Med. Chem., 2012,
55, 10995; (c) C. Dubiella, H. Cui, M. Gersch, A. J. Brouwer,
S. A. Sieber, A. Krüger, R. M. J. Liskamp and M. Groll,
Angew. Chem., Int. Ed., 2014, 53, 11969; (d) O. Vosyka,
K. R. Vinothkumar, E. V. Wolf, A. J. Brouwer,
R. M. J. Liskamp and S. H. L. Verhelst, Proc. Natl. Acad.
Sci. U. S. A., 2013, 110, 2472.
23 S. Tschan, A. J. Brouwer, P. R. Werkhoven, A. M. Jonker,
L. Wagner, S. Knittel, M. N. Aminake, G. Pradel, F. Joanny,
R. M. J. Liskamp and B. Mordmüller, Antimicrob. Agents
Chemother., 2013, 57, 3576.
Organic & Biomolecular Chemistry Paper
This journal is © The Royal Society of Chemistry 2015 Org. Biomol. Chem., 2015, 13, 4514–4523 | 4523
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 1
0 
M
ar
ch
 2
01
5.
 D
ow
nl
oa
de
d 
on
 2
5/
05
/2
01
5 
16
:0
3:
40
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n 
3.
0 
U
np
or
te
d 
Li
ce
nc
e.
View Article Online
